APA aipamena

Palazzo, M., Shah, G. L., Copelan, O., Seier, K., Devlin, S. M., Maloy, M., . . . Perales, M. (2017). Re-vaccination following Autologous Hematopoietic Stem Cell Transplantation is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance. Biol Blood Marrow Transplant.

Chicago Style aipamena

Palazzo, Meighan, et al. "Re-vaccination Following Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients With Multiple Myeloma Receiving Lenalidomide Maintenance." Biol Blood Marrow Transplant 2017.

MLA aipamena

Palazzo, Meighan, et al. "Re-vaccination Following Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients With Multiple Myeloma Receiving Lenalidomide Maintenance." Biol Blood Marrow Transplant 2017.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.